About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Clinical Guidelines to Treat Mitochondrial Diseases Released

by Anjali Aryamvally on October 25, 2017 at 11:43 AM
Font : A-A+

New Clinical Guidelines to Treat Mitochondrial Diseases Released

At least one in 4,500 individuals are affected with mitochondrial diseases caused by defects in genes affecting the function of mitochondria, a crucial energy-producing structures found in every cell. However, the standard care for treating these diseases is not uniform. Physicians now have a practical new tool--a set of guidelines for managing and caring for patients with mitochondrial diseases.

"Standards of care are not uniform across centers or clinicians. To take just one example, clinicians need to know how often to order laboratory tests to monitor the health of patients with mitochondrial disease," said study co-leader Amy Goldstein, MD, newly appointed clinical director of the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP), and current president of the Mitochondrial Medicine Society (MMS), which issued the consensus statement. "Our guidelines reflect expert consensus based on our current knowledge of mitochondrial medicine."

Advertisement


The MMS patient care standards for primary mitochondrial disease appeared online July 27, 2017 in Genetics in Medicine. The study leader and corresponding author is Sumit Parikh, MD, of the Cleveland Clinic Children's Hospital.

The MMS previously issued consensus criteria in 2015 to guide diagnosis of mitochondrial disease. It subsequently surveyed over 200 clinicians worldwide who see mitochondrial patients, and found that 99 percent of those practitioners, including neurologists, geneticists and metabolic experts, wanted additional guidelines to assist in managing patient care. In addition, said Goldstein, "patients and families have been asking for a guidelines document to bring to their own physicians."
Advertisement

For the current study, the MMS appointed an international panel of 35 mitochondrial medicine specialists to review current knowledge and develop recommendations.

Reflecting the systemic impact of energy deficiencies caused by impaired mitochondrial function, the group's recommendations address a broad range of medical specialties, including cardiology, neurology, critical care medicine, nephrology, endocrinology, audiology and ophthalmology.

In addition, the guidelines address special issues encountered by patients during pregnancy and high-altitude travel, and also compile a list of medications, such as statins and acetaminophen, that must be used with caution or avoided in patients with mitochondrial disease.

While the current guidelines are the first set of published recommendations for patient management and clinical care decisions, the authors recognize that as mitochondrial medicine continues to evolve, the guidelines will need to be updated.

These guidelines represent an important step in the effort to standardize health care and optimize health outcomes for mitochondrial disease patients. They also establish a baseline from which meaningful clinical trials can be launched to evaluate new treatment interventions.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
High Costs of Mitochondrial Diseases Spell Urgent Need for Better Therapies
Mutated genes may cause a group of disorders called as Mitochondrial diseases. The high cost of ......
New Online Database Provides Answers On Mitochondrial Diseases
A new tool has been created called the POLG Pathogenicity Prediction Server. POLG helps clinicians ....
Novel Discovery Could Lead to Treatments for Mitochondrial Diseases
Embryos with 'heteroplasmy', or the presence of both maternal and paternal mitochondrial DNA, have ....
Mitochondrial Diseases Have a Remedy by 'Three Parent' Invitro Fertilisation
The IVF procedure involves the use of biological material from three "parents" to prevent the ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)